Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


2 Am J Cardiol
1 Cardiovasc Res
2 Circ Res
3 Eur Heart J
6 Eur J Heart Fail
4 Heart
1 Int J Cardiol
1 J Am Coll Cardiol
9 J Card Fail
3 J Mol Cell Cardiol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. TSUSHIMA T, Main A, Al-Kindi SG, Dallan LAP, et al
    Risk Stratification of New Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2022 May 18. pii: S0002-9149(22)00405.
    PubMed         Abstract available

  2. HENDRICKSON MJ, Arora S, Chew C, Sharma M, et al
    Contemporary Trends and Comparison of Racial Differences in Hospitalizations of Adults With Congenital Heart Disease.
    Am J Cardiol. 2022 May 16. pii: S0002-9149(22)00409.
    PubMed         Abstract available


  3. LEE KK, Doudesis D, Anwar M, Astengo F, et al
    Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.
    BMJ. 2022;377:e068424.
    PubMed         Abstract available

    Cardiovasc Res

  4. HERON C, Dumesnil A, Houssari M, Renet S, et al
    Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.
    Cardiovasc Res. 2022 Jun 11. pii: 6605782. doi: 10.1093.
    PubMed         Abstract available

    Circ Res

  5. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022 Jun 14:101161CIRCRESAHA121319817.
    PubMed         Abstract available

  6. BUGGER H, Byrne NJ, Abel ED
    Animal Models of Dysregulated Cardiac Metabolism.
    Circ Res. 2022;130:1965-1993.
    PubMed         Abstract available

    Eur Heart J

  7. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.

  8. FERREIRA JP, Zannad F, Butler J, Filipattos G, et al
    Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
    Eur Heart J. 2022 Jun 10. pii: 6605266. doi: 10.1093.
    PubMed         Abstract available

  9. CRESPO-LEIRO MG, Costanzo MR, Gustafsson F, Khush KK, et al
    Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies.
    Eur Heart J. 2022 Apr 20. pii: 6571226. doi: 10.1093.
    PubMed         Abstract available

    Eur J Heart Fail

  10. BHATT AS, Vaduganathan M, Solomon SD, Schneeweiss S, et al
    Sacubitril/Valsartan Use Patterns among Older Adults with Heart Failure in Clinical Practice: A Population-Based Cohort Study of >25,000 Medicare Beneficiaries.
    Eur J Heart Fail. 2022 Jun 11. doi: 10.1002/ejhf.2572.
    PubMed         Abstract available

  11. INCIARDI RM, Chandra A
    Epicardial Adipose Tissue in Heart Failure: Risk Factor or Mediator?
    Eur J Heart Fail. 2022 Jun 15. doi: 10.1002/ejhf.2577.

  12. LUND LH, Pitt B, Metra M
    Left ventricular ejection fraction as the primary heart failure phenotyping parameter.
    Eur J Heart Fail. 2022 Jun 15. doi: 10.1002/ejhf.2576.

  13. SEFEROVIC P, Farmakis D, Bayes-Genis A, Ben Gal T, et al
    Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: A position statement from the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2022 Jun 15. doi: 10.1002/ejhf.2575.
    PubMed         Abstract available

  14. BURRAGE MK, Valkovic L, Rider OJ
    Letter regarding the article "Cardiac Energetics in Patients with Chronic Heart Failure and Iron Deficiency: An in-vivo 31P Magnetic Resonance Study".
    Eur J Heart Fail. 2022 Jun 15. doi: 10.1002/ejhf.2574.

  15. KOBAYASHI M, Girerd N, Ferreira JP, Kevin D, et al
    The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
    Eur J Heart Fail. 2022 Jun 15. doi: 10.1002/ejhf.2579.
    PubMed         Abstract available


  16. KEENAN J, Pal J
    The need for speed: modulating left ventricular assist device flow in response to varying physiological conditions.
    Heart. 2022;108:996-997.

  17. STAPOR M, Pilat A, Gackowski A, Misiuda A, et al
    Echo-guided left ventricular assist device speed optimisation for exercise maximisation.
    Heart. 2022;108:1055-1062.
    PubMed         Abstract available

  18. GIBLETT JP, Williams LK, Moorjani N, Calvert PA, et al
    Percutaneous management of paravalvular leaks.
    Heart. 2022;108:1005-1011.
    PubMed         Abstract available

  19. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed         Abstract available

    Int J Cardiol

  20. LI S, Zheng Y, Huang Y, He W, et al
    Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis.
    Int J Cardiol. 2022;361:40-46.
    PubMed         Abstract available

    J Am Coll Cardiol

  21. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    PubMed         Abstract available

    J Card Fail

  22. CISOWSKA T, Pan IZ, Biskupiak J, Shah KS, et al
    Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: A retrospective cohort study.
    J Card Fail. 2022 Jun 7. pii: S1071-9164(22)00539.
    PubMed         Abstract available

  23. PIERCE JB, Mentz RJ, Sun JL, Alhanti B, et al
    Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: findings from the HF-ACTION trial.
    J Card Fail. 2022 Jun 7. pii: S1071-9164(22)00538.
    PubMed         Abstract available

  24. LU Y, Jones PW, Murugiah K, Caraballo C, et al
    Cardiac Status Among Heart Failure Patients with Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown.
    J Card Fail. 2022 Jun 8. pii: S1071-9164(22)00540.
    PubMed         Abstract available

  25. SAHA A, Patel KV, Ayers C, Ballantyne CM, et al
    Longitudinal changes in cardiac troponin and risk of heart failure among Black adults.
    J Card Fail. 2022 Jun 8. pii: S1071-9164(22)00542.
    PubMed         Abstract available

  26. JOHNSON KW, Patel S, Thapi S, Jaladanki SK, et al
    Association of Reduced Hospitalizations and Mortality Among COVID-19 Vaccinated Patients with Heart Failure.
    J Card Fail. 2022 Jun 6. pii: S1071-9164(22)00536.
    PubMed         Abstract available

  27. KRUITHOFF M, Sawyer D, Egorova D, Hutchinson RN, et al
    Heart to Heart Discussions: Characterizing Goals of Care Conversations for Advanced Heart Failure Patients Initiating Palliative Inotropes.
    J Card Fail. 2022 Jun 9. pii: S1071-9164(22)00541.
    PubMed         Abstract available

  28. COLES TM, Lin L, Weinfurt K, Reeve BB, et al
    Do PRO measures function the same way for all individuals with heart failure?
    J Card Fail. 2022 Jun 9. pii: S1071-9164(22)00545.
    PubMed         Abstract available

  29. MASTORIS I, Van Spall HGC, Sauer AJ
    Can we stop reflexively discontinuing mineralocorticoid antagonists for patients with heart failure and hyperkalemia?
    J Card Fail. 2022 Jun 9. pii: S1071-9164(22)00543.

  30. HERRMANN JJ, Beckers-Wesche F, Baltussen LEHJM, Verdijk MHI, et al
    Fluid REStriction in Heart failure versus liberal fluid UPtake: Rationale and design of the randomised FRESH-UP study.
    J Card Fail. 2022 Jun 12. pii: S1071-9164(22)00544.
    PubMed         Abstract available

    J Mol Cell Cardiol

  31. BODE D, Sotomayor-Flores C, Schiattarella GG
    Up next: The dawn of systems biology in HFpEF research.
    J Mol Cell Cardiol. 2022;168:96-97.

  32. WITHAAR C, Li S, Meems LMG, Sillje HHW, et al
    Aging and HFpEF: Are we running out of time?
    J Mol Cell Cardiol. 2022;168:33-34.

    A misdirected conundrum in translational HFpEF research.
    J Mol Cell Cardiol. 2022;168:1-2.

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.